Trial intelligence / Profile preview

Lidocaine and dexmedetomidine for gag reflex suppression during upper endoscopy under propofol anesthesia

IRCT20190928044907N5Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial comparing Propofol alone, Dexmedetomidine plus propofol and Topical lidocaine (3 arms). Primary endpoint: Gag reflex. Started Oct 2023; status: completed.

02

Drugs

propofoldexmedetomidinelidocaine

Beyond the preview

Go deeper on IRCT20190928044907N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190928044907N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call